All Title Author
Keywords Abstract

PLOS ONE  2012 

Bronchoalveolar Lavage Enzyme-Linked Immunospot for Diagnosis of Smear-Negative Tuberculosis in HIV-Infected Patients

DOI: 10.1371/journal.pone.0039838

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Peripheral blood interferon-gamma release assays (IGRAs) have sub-optimal sensitivity and specificity for diagnosis of active pulmonary tuberculosis (TB). However, assessment of local immune responses has been reported to improve the accuracy of TB diagnosis. Methods We enrolled HIV-infected adults with cough ≥2 weeks’ duration admitted to Mulago Hospital in Kampala, Uganda and referred for bronchoscopy following two negative sputum acid-fast bacillus smears. We performed an ELISPOT-based IGRA (T-SPOT.TB?, Oxford Immunotec, Oxford, UK) using peripheral blood and bronchoalveolar lavage (BAL) fluid mononuclear cells, and determined the accuracy of IGRAs using mycobacterial culture results as a reference standard. Results 94 HIV-infected patients with paired peripheral blood and BAL IGRA results were included. The study population was young (median age 34 years [IQR 28–40 years]) and had advanced HIV/AIDS (median CD4+ T-lymphocyte count 60 cells/μl [IQR 22–200 cells/μl]). The proportion of indeterminate IGRA results was higher in BAL fluid than in peripheral blood specimens (34% vs. 14%, difference 20%, 95% CI 7–33%, p = 0.002). BAL IGRA had moderate sensitivity (73%, 95% CI 50–89%) but poor specificity (48%, 95% CI 32–64%) for TB diagnosis. Sensitivity was similar (75%, 95% CI 57–89%) and specificity was higher (78%, 95% CI 63–88%) when IGRA was performed on peripheral blood. Conclusions BAL IGRA performed poorly for the diagnosis of smear-negative TB in a high HIV/TB burden setting. Further studies are needed to examine reasons for the large proportion of indeterminate results and low specificity of BAL IGRA for active TB in high HIV/TB burden settings.

References

[1]  Centers for Disease Control and Prevention (2010) Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection - United States, 2010. MMWR 59.
[2]  Canadian Tuberculosis Committee (2010) Updated Recommendations on Interferon Gamma Release Assays for Latent Tuberculosis Infection. CCDR 36: 1–21.
[3]  Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. (2011) Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 204: S1120–1129.
[4]  Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230–238.
[5]  Barry SM, Lipman MC, Bannister B, Johnson MA, Janossy G (2003) Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. J Infect Dis 187: 243–250.
[6]  Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, et al. (1993) Cytokine production at the site of disease in human tuberculosis. Infect Immun 61: 3482–3489.
[7]  Jafari C, Ernst M, Strassburg A, Greinert U, Kalsdorf B, et al. (2008) Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J 31: 261–265.
[8]  Jafari C, Thijsen S, Sotgiu G, Goletti D, Dominguez Benitez JA, et al. (2009) Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med 180: 666–673.
[9]  Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, et al. (2010) Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. Eur Respir J 36: 446–448.
[10]  Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, et al. (2010) Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis 10: 75.
[11]  Davis JL, Worodria W, Kisembo H, Metcalfe JZ, Cattamanchi A, et al. (2010) Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. PLoS One 5: e9859.
[12]  Lancioni C, Nyendak M, Kiguli S, Zalwango S, Mori T, et al. (2011) CD8+ T cells Provide an Immunologic Signature of Tuberculosis in Young Children. Am J Respir Crit Care Med.
[13]  Jafari C, Ernst M, Kalsdorf B, Greinert U, Diel R, et al. (2006) Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 174: 1048–1054.
[14]  Jafari C, Kessler P, Sotgiu G, Ernst M, Lange C (2011) Impact of a Mycobacterium tuberculosis-specific interferon-gamma release assay in bronchoalveolar lavage fluid for a rapid diagnosis of tuberculosis. J Intern Med 270: 254–262.
[15]  Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, et al. (2009) Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 64: 847–853.
[16]  Kalsdorf B, Scriba TJ, Wood K, Day CL, Dheda K, et al. (2009) HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med 180: 1262–1270.
[17]  Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, et al. (2007) Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 30: 1173–1179.
[18]  Baba K, Sornes S, Hoosen AA, Lekabe JM, Mpe MJ, et al. (2008) Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay. BMC Infect Dis 8: 35.
[19]  Dheda K, van Zyl-Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. Eur Respir J 34: 1118–1126.
[20]  Lukwiya M, Rizzardini G, Trabattoni D, Piconi S, Saresella M, et al. (2001) Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production. J Acquir Immune Defic Syndr 28: 429–436.
[21]  Clerici M, Butto S, Lukwiya M, Saresella M, Declich S, et al. (2000) Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. AIDS 14: 2083–2092.
[22]  Desai S, Landay A (2010) Early immune senescence in HIV disease. Curr HIV/AIDS Rep 7: 4–10.
[23]  Caccamo N, Meraviglia S, La Mendola C, Guggino G, Dieli F, et al. (2006) Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens. J Immunol 177: 1780–1785.
[24]  Chien HP, Yu MC, Wu MH, Lin TP, Luh KT (2000) Comparison of the BACTEC MGIT 960 with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 4: 866–870.

Full-Text

comments powered by Disqus